Following the sale-and-leaseback purchase of Oxford Biomedica's Oxford headquarters in 2022, life sciences specialist Kadans Science Partner has announced a development deal for the property next door.
Swiss real estate group Investis has boosted its real estate holdings with the CHF 139 mln (€149 mln) purchase of prime residential properties in Vaud canton.
